The Cinnamon study
Research type
Research Study
Full title
Managing malodour in malignant fungating wounds with a cinnamon-containing dressing: a prospective observational study.
IRAS ID
352998
Contact name
Fania Pagnamenta
Contact email
Sponsor organisation
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Clinicaltrials.gov Identifier
n/a, n/a
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
The malodour emanating from malignant fungating wounds can be source of significant discomfort for patients, and can affect relationships with their relatives, carers and nursing staff, especially challenging during their end of life, defined as the last year of their life.
There are several dressings on the market that attempt to control malodour in chronic wounds, but there are no conclusive data on their efficacy. Dressings based charcoal or silver do not control malodour once the dressing gets wet with exudate and topical applications of antibiotics have limited efficacy. Alternative solutions are used such as aromatherapy, scented candles, deodorising sprays or even cat litter to absorb malodour, with variable effect.
A cinnamon-containing dressing (Cinesteam®, Cimag, Paris) was specially developed to reduce and manage malodorous wounds. It is a mildy absorbant dressing that contains a sachet of cinnamon, which eliminates odours by adsorbing volatile compounds emanating from the wound and deodorising any residual malodours. Currently, this is only cinnamon- containing dressing on the market.
The aim of this study is to understand if this cinnamon-containing dressing can reduce patients’ discomfort associated with malodour in malignant fungating wounds.REC name
North of Scotland Research Ethics Committee 2
REC reference
25/NS/0024
Date of REC Opinion
25 Mar 2025
REC opinion
Further Information Favourable Opinion